Oral probiotic control skin inflammation by acting on both effector and regulatory T cells

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Hacini Rachinel, Feriel ^a,b,c   Gheit, Hanane ^a,b,c   Le Luduec, Jean Benoit ^a,b,c   Dif, Fariel ^d   Nancey, Stéphane ^a,b,c,e   Kaiserlian, Dominique ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c University Lyon i   (France)

^d DANONE RESEARCH   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; LACTOBACILLUS CASEI EXTRACT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROBIOTIC AGENT; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; EFFECTOR CELL; FEMALE; HAPTEN CARRIER COMPLEX; IMMUNOMODULATION; LYMPH NODE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; SKIN ALLERGY; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL TRANSPLANTATION; CYTOLOGY; HUMAN; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGICAL EXAMINATION; ORAL DRUG ADMINISTRATION; SKIN; T LYMPHOCYTE SUBPOPULATION;

MUS;

ADMINISTRATION, ORAL; ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; SKIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 63749121653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004903     Document Type: Article

References (35)

1. Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, et al. (2003) New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37: 105-118.
2. Boirivant M, Strober W (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23: 679-692.
3. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
4. Lee J, Seto D, Bielory L (2008) Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 121: 116-121 e111.
5. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309.
6. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174: 3237-3246.
7. Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, et al. (2007) A key role of dendritic cells in probiotic functionality. PLoS ONE 2: e313.
8. Nancey S, Holvoet S, Graber I, Joubert G, Philippe D, et al. (2006) CD8+ cytotoxic T cells induce relapsing colitis in normal mice. Gastroenterology 131: 485-496.
9. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
10. Enk AH, Katz SI (1995) Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 105: 80S-83S.
11. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D (2004) Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur J Immunol 34: 2520-2528.
12. Cavani A, Mei D, Guerra E, Corinti S, Giani M, et al. (1998) Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol 111: 621-628.
13. Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, et al. (2006) CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 126: 815-820.
14. Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183: 1001-1012.
15. Bour H, Peyron E, Gaucherand M, Garrigue JL, Desvignes C, et al. (1995) Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 25: 3006-3010.
16. Krasteva M, Kehren J, Horand F, Akiba H, Choquet G, et al. (1998) Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol 160: 1181-1190.
17. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, et al. (1999) Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 189: 779-786.
18. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, et al. (2002) Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 168: 3079-3087.
19. Desvignes C, Etchart N, Kehren J, Akiba I, Nicolas JF, et al. (2000) Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. J Immunol 164: 2515-2522.
20. Okazaki F, Kanzaki H, Fujii K, Arata J, Akiba H, et al. (2002) Initial recruitment of interferon-gamma-producing CD8+ effector cells, followed by infiltration of CD4+ cells in 2,4,6-trinitro-1-chlorobenzene (TNCB)-induced murine contact hypersensitivity reactions. J Dermatol 29: 699-708.
21. Dubois B, Chapat L, Goubier A, Papiernik M, Nicolas JF, et al. (2003) Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 102: 3295-3301.
22. Mahnke K, Ring S, Johnson TS, Schallenberg S, Schonfeld K, et al. (2007) Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 37: 2117-2126.
23. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, et al. (2003) Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 171: 5760-5768.
24. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, et al. (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24: 191-201.
25. Goubier A, Dubois B, Gheit H, Joubert G, Villard-Truc F, et al. (2008) Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29: 464-475.
26. Roelofs-Haarhuis K, Wu X, Gleichmann E (2004) Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 173: 1043-1050.
27. So JS, Kwon HK, Lee CG, Yi HJ, Park JA, et al. (2008) Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol Immunol 45: 2690-2699.
28. Chen JP, Liao NS, Lai SL, Hsu L, Mao WY, et al. (2005) Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor alpha-deficient mice correlates with diminished CCL5/ RANTES and CXCL10/IP-10 expression. Eur J Immunol 35: 690-698.
29. Ring S, Schafer SC, Mahnke K, Lehr HA, Enk AH (2006) CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 36: 2981-2992.
30. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, et al. (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197: 403-411.
31. Sheil B, McCarthy J, O'Mahony L, Bennett MW, Ryan P, et al. (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53: 694-700.
32. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, et al. (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53: 821-828.
33. Macpherson AJ, Uhr T (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662-1665.
34. Schultz M, Watzl S, Oelschlaeger TA, Rath HC, Gottl C, et al. (2005) Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo. J Microbiol Methods 61: 389-398.
35. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M (2008) Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol 84: 468-476.